Literature DB >> 35976421

Electrostimulus-triggered reactive oxygen species level in organelles revealed by organelle-targeting SERS nanoprobes.

Jiaming Chen1,2, Xiaozhang Qu1,2,3, Guohua Qi4, Weiqing Xu1,2, Yongdong Jin4, Shuping Xu5,6,7.   

Abstract

Electrostimulation (ES) is an important therapeutic method for diseases caused by abnormal intracellular electrical activity. Also, it can induce apoptosis of cells, which is a potential tumor treatment method. At present, there are no relevant studies on changes in intracellular reactive oxygen species (ROS) levels produced in the process of ES, or on the effects of simultaneous implementation of conventional antioxidant inhibitor drugs and ES therapy. To reveal these, two organelle-targeting core-shell plasmonic probes were designed for measuring ROS produced during ES. The probes were delivered into target organelles (nucleus and mitochondrion) before the cells were electrically stimulated for different periods of time. Surface-enhanced Raman scattering (SERS) signals were detected in situ, and the sensing mechanism for the quantitative analysis of ROS is based on the signal reduction of SERS caused by the ROS-etching effect on the silver shell. The detection results revealed that ES could trigger ROS generation in cells, and the ROS levels localized around organelles were assessed by SERS. This study has great potential for exploring abnormal organelle microenvironments via organelle-targeting probes combined with SERS technology.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Electrostimulus; Organelles; Reactive oxygen species; Surface-enhanced Raman scattering

Mesh:

Substances:

Year:  2022        PMID: 35976421     DOI: 10.1007/s00216-022-04265-3

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  31 in total

1.  Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles.

Authors:  Limin Pan; Qianjun He; Jianan Liu; Yu Chen; Ming Ma; Linlin Zhang; Jianlin Shi
Journal:  J Am Chem Soc       Date:  2012-03-20       Impact factor: 15.419

Review 2.  Mitochondrial ROS control of cancer.

Authors:  María Del Pilar Sosa Idelchik; Ulrike Begley; Thomas J Begley; J Andrés Melendez
Journal:  Semin Cancer Biol       Date:  2017-04-23       Impact factor: 15.707

Review 3.  Redox-dependent signal transduction.

Authors:  T Finkel
Journal:  FEBS Lett       Date:  2000-06-30       Impact factor: 4.124

Review 4.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

Authors:  Simran S Sabharwal; Paul T Schumacker
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

5.  Construction and evaluation of tumor nucleus-targeting nanocomposite for cancer dual-mode imaging - Guiding photodynamic therapy/photothermal therapy.

Authors:  Jie Zhou; Qiaolei Wang; Shizhen Geng; Rui Lou; Qianwen Yin; Weiran Ye
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-04-28       Impact factor: 7.328

Review 6.  Recent advances of electrochemical sensors for detecting and monitoring ROS/RNS.

Authors:  Shuang Zhao; Guangchao Zang; Yuchan Zhang; Huawen Liu; Nan Wang; Shangjun Cai; Colm Durkan; Guoming Xie; Guixue Wang
Journal:  Biosens Bioelectron       Date:  2021-02-11       Impact factor: 10.618

Review 7.  Oxidative stress in prostate cancer.

Authors:  Lakshmipathi Khandrika; Binod Kumar; Sweaty Koul; Paul Maroni; Hari K Koul
Journal:  Cancer Lett       Date:  2009-01-30       Impact factor: 8.679

Review 8.  Therapeutic strategies by modulating oxygen stress in cancer and inflammation.

Authors:  Jun Fang; Takahiro Seki; Hiroshi Maeda
Journal:  Adv Drug Deliv Rev       Date:  2009-02-26       Impact factor: 15.470

Review 9.  Oxidative Stress in Cancer Cell Metabolism.

Authors:  Saniya Arfin; Niraj Kumar Jha; Saurabh Kumar Jha; Kavindra Kumar Kesari; Janne Ruokolainen; Shubhadeep Roychoudhury; Brijesh Rathi; Dhruv Kumar
Journal:  Antioxidants (Basel)       Date:  2021-04-22

Review 10.  Mitochondria-targeted antioxidants.

Authors:  Anne O Oyewole; Mark A Birch-Machin
Journal:  FASEB J       Date:  2015-08-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.